Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Tiotropium on Exercise Tolerance in COPD
NCT00274508Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Oct 2000
- Primary completion
- Jan 2003
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 3, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Tiotropium with Placebo (2 arms). Primary endpoint: Endurance time during a constant work rate exercise test to symptom limitation at Day 42. Started Oct 2000; status: completed.
02
Drugs
tiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00274508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00274508.